PATENT CLAIM ANALYSIS

Application Number: 16162670
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "177000"]

Abstract:
Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.

Claim (Index 68):
The transdermal patch of  claim 52 , wherein the transdermal patch is a transdermal liquid system patch.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 97.0
- Lexical Diversity: 1.34615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11205297', '12543859', '10621711', '12556740', '14080948']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7931577072293976
- 35 USC 102 Novelty (BERT): 0.5616715913582354
- Combined Prediction Score: 0.7700090956422814
- Mean Citation Score: 322.774764
- Max Citation Score: 480.39188
- Similarity Product: 312.53365895462986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test